Sleep Disorders Trial, Recruiting (NCT04092660)

Sleep Disorders Trial, Recruiting NCT04092660 Sponsor: Queen Mary University of London Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT04092660 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 40 years or older
People who have a confirmed diagnosis of obstructive sleep apnoea (a condition where breathing repeatedly stops during sleep), with a test result showing 5 or more breathing interruptions per hour
People who have been referred for treatment with a mandibular advancement appliance (a custom-fitted mouthguard-like device worn during sleep to help keep the airway open)
People who can read, write, and understand English, including with the help of a translator

Who may not be able to join:

People who do not have enough teeth for a mandibular advancement appliance to be made and fitted
People with poor dental health or gum disease
People who are currently experiencing symptoms from a jaw joint condition known as temporomandibular disorder (pain or problems with the jaw joint and surrounding muscles)
People who have previously used a mandibular advancement appliance
People who have epilepsy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ama Johal, Queen Mary University of London

Phone: 0207 377 7686

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04092660

Sponsor: Queen Mary University of London

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 0207 377 7686

More information: https://clinicaltrials.gov/study/NCT04092660

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 40 years or older
People who have a confirmed diagnosis of obstructive sleep apnoea (a condition where breathing repeatedly stops during sleep), with a test result showing 5 or more breathing interruptions per hour
People who have been referred for treatment with a mandibular advancement appliance (a custom-fitted mouthguard-like device worn during sleep to help keep the airway open)
People who can read, write, and understand English, including with the help of a translator

Who may not be able to join:

People who do not have enough teeth for a mandibular advancement appliance to be made and fitted
People with poor dental health or gum disease
People who are currently experiencing symptoms from a jaw joint condition known as temporomandibular disorder (pain or problems with the jaw joint and surrounding muscles)
People who have previously used a mandibular advancement appliance
People who have epilepsy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Queen Mary University of London

Registry

ClinicalTrials.gov

Start date

6 December 2019

Est. completion

1 June 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Adherence- the number of hours the patient uses the MAA or anti-snoring mouth guard every night; Adherence-the number of hours the patient uses the MAA or anti-snoring mouth guard

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov